Meningococcal meningitis are a major cause of bacterial meningitis and septicemia, usually occurs during infancy, adolescence and young adulthood and is characterized by an infectious syndrome with meningismus. Aggressive early treatment of meningococcal disease can reduce mortality.
This report contains market size and forecasts of Meningococcal Infections Treatment in Global, including the following market information:
Global Meningococcal Infections Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Meningococcal Infections Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antibiotics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Meningococcal Infections Treatment include Pfizer, Sanofi, GlaxoSmithKline and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Meningococcal Infections Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Meningococcal Infections Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Meningococcal Infections Treatment Market Segment Percentages, by Type, 2021 (%)
Antibiotics
Glucocorticoids
Protein C Concentrate
Global Meningococcal Infections Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Meningococcal Infections Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Meningococcal Infections Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Meningococcal Infections Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Meningococcal Infections Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Meningococcal Infections Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Sanofi
GlaxoSmithKline
Novartis